USFDA classifies Emcure Pharmaceuticals Ltd's API facility at Kurkumbh as VAI

Pursuant to the the United States Food & Drug Administration ("USFDA") inspection at Emcure Pharmaceuticals Limited's API manufacturing facility located at M.I.D.C., Kurkumbh, Taluka - Daund, Pune - 413802, Maharashtra, the Company has received the Establishment Inspection Report (EIR). The USFDA has classified the inspection of the facility as "Voluntary Action Indicated" (VAI).

Shares of Emcure Pharmaceuticals Limited was last trading in BSE at Rs. 1094.65 as compared to the previous close of Rs. 1003.05. The total number of shares traded during the day was 28802 in over 1976 trades.

The stock hit an intraday high of Rs. 1103.35 and intraday low of 1010.10. The net turnover during the day was Rs. 30933888.00.

Source : Equity Bulls

Keywords

EmcurePharmaceuticals INE168P01015 APIManufacturingFacility USFDA EIR VAI